v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Provided by (Used in) Operating Activities    
Net earnings $ 6,995 $ 5,830
Adjustments to reconcile net earnings to operating cash flows:    
Depreciation and amortization 172 212
Deferred income tax provision (benefit) 93 (194)
Unrecognized tax benefit [1] 0 291
Fair value adjustment for NJOY Transaction contingent payments, net of cash paid 0 25
(Income) losses from investments in equity securities (487) (398)
Dividends from ABI 186 181
Exit costs, net of cash paid 7 (9)
Impairment of goodwill 0 873
Cash effects of changes:    
Receivables (79) (72)
Inventories (72) (22)
Accounts payable 43 (30)
Income taxes 322 404
Accrued liabilities and other current assets (934) (856)
Accrued settlement charges (236) (467)
Pension plan contributions (13) (11)
Pension and postretirement, net (13) (60)
Other, net 167 322
Net cash provided by (used in) operating activities 6,151 6,019
Cash Provided by (Used in) Investing Activities    
Capital expenditures (259) (124)
Other, net (16) (15)
Net cash provided by (used in) investing activities (275) (139)
Cash Provided by (Used in) Financing Activities    
Long-term debt issued 0 1,992
Long-term debt repaid (1,569) (1,607)
Repurchases of common stock (735) (712)
Dividends paid on common stock (5,330) (5,175)
Other, net (23) (40)
Net cash provided by (used in) financing activities (7,657) (5,542)
Cash, cash equivalents and restricted cash:    
Increase (decrease) [1] (1,781) 338
Balance at beginning of period [1] 4,492 3,158
Balance at end of period [1] $ 2,711 $ 3,496
[1] For a reconciliation to our condensed consolidated balance sheets, see Note 13. Additional Financial Statement Information - Cash, Cash Equivalents and Restricted Cash.